University of Birmingham
Project 1: Anti-leukemic action of bezafibrate and medroxyprogesterone acetate in myeloid leukemia cells AND Project 2: Analysis of putative cis-regulatory elements in type 2 diabetes associated genes using zebrafish model
Abstract
dc:description.abstractProject 1: Combined bezafibrate and medroxyprogesterone acetate (BaP) exert potent anti- leukemic activity in leukemic cell lines whilst avoiding damage of healthy cells. Western blot and RT-PCR analyses identified alterations in levels of key enzymes involved in maintaining lipogenic/lipolytic balance in BaP treated samples when compared to control samples. This research provides insight in to the anti-leukemic mechanism by which BaP applies its powerful effects. Project 2: With the ever-expanding knowledge obtained by genome-wide studies, the importance and complexity of transcription has become increasingly evident. From acquired knowledge, advanced technology in the form of computer analysis can now predict the presence of cis-regulatory elements; however these ex vivo systems cannot validate such predictions. This study has shown transgenic zebrafish can be used as a model to express when driven by the common form of the PROX enhancer (PROX-G) and also its type 2 diabetes associated SNP variant counter-part, PROX-A; when integrated in to the genome using targeted integration system mediated by PhiC31 integrase. The use of PhiC31 showed promising transmission rate whilst over-coming problems associated with other transgenesis systems, namely position effect.
Degree
thesis:*- Name dc:type.qualificationname
- m_rs
- Level dc:type.qualificationlevel
- m_rs
- Grantor dc:publisher.institution
- University of Birmingham
- Year dc:date.issued
- 2015
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Constantinou, Julia
Subjects
dc:subject × 2Rights
- Language dc:language.dcterms_iso639_2
- eng